Geneos Wealth Management’s ResMed RMD Stock Holding History

Geneos Wealth Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.31K	Buy	17 +13	+325%	+$2.69K	﹤0.01%	2257
2026 Q1	$898	Hold	4	–	–	﹤0.01%	2419
2025 Q4	$963	Hold	4	–	–	﹤0.01%	2411
2025 Q3	$1.09K	Sell	4 -69	-95%	-$18.8K	﹤0.01%	2396
2025 Q2	$18.8K	Buy	73 +9	+14%	+$2.15K	﹤0.01%	2053
2025 Q1	$34.7K	Buy	64 +18	+39%	+$4.2K	﹤0.01%	2097
2024 Q4	$10.5K	Hold	46	–	–	﹤0.01%	2035
2024 Q3	$11.2K	Buy	46 +35	+318%	+$7.82K	﹤0.01%	1795
2024 Q2	$2.11K	Hold	11	–	–	﹤0.01%	1876
2024 Q1	$2.18K	Hold	11	–	–	﹤0.01%	1886
2023 Q4	$1.89K	Buy	11 +4	+57%	+$615	﹤0.01%	1929
2023 Q3	$1.03K	Hold	7	–	–	﹤0.01%	2023
2023 Q2	$1.53K	Hold	7	–	–	﹤0.01%	1970
2023 Q1	$1.53K	Hold	7	–	–	﹤0.01%	1944
2022 Q4	$1.46K	Hold	7	–	–	﹤0.01%	1920
2022 Q3	$1K	Hold	7	–	–	﹤0.01%	1961
2022 Q2	$1K	Hold	7	–	–	﹤0.01%	2531
2022 Q1	$1K	Hold	7	–	–	﹤0.01%	2684
2021 Q4	$1K	Hold	7	–	–	﹤0.01%	2704
2021 Q3	$1K	Hold	7	–	–	﹤0.01%	2778
2021 Q2	$1K	Sell	7 -31	-82%	-$6.52K	﹤0.01%	2790
2021 Q1	$7K	Hold	38	–	–	﹤0.01%	2548
2020 Q4	$1K	Buy	38 +31	+443%	+$6.18K	﹤0.01%	2821
2020 Q3	$1K	Hold	7	–	–	﹤0.01%	2560
2020 Q2	$1K	Buy	+7	New	+$1.15K	﹤0.01%	2499
2020 Q1	–	Sell	-7	Closed	-$1K	–	2583
2019 Q4	$1K	Buy	+7	New	+$1.01K	﹤0.01%	2492
2017 Q1	–	Sell	-160	Closed	-$9K	–	2123
2016 Q4	$9K	Hold	160	–	–	﹤0.01%	1474
2016 Q3	$10K	Hold	160	–	–	﹤0.01%	1373
2016 Q2	$10K	Sell	160 -1,421	-90%	-$83.8K	﹤0.01%	1332
2016 Q1	$93K	Buy	+1,581	New	+$89.5K	0.01%	608

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geneos Wealth Management's RMD Position: Q2 2026 in Review

Geneos Wealth Management increased its ResMed (RMD) stake by 325% in Q2 2026, buying an estimated $2.69K and bringing the position to 17 shares worth $3.31K. The position accounts for ﹤0.01% of the portfolio, ranked #2257.

Geneos Wealth Management first reported a position in RMD in Q1 2016 and has held it in 30 quarters since. The position peaked at $93K in Q1 2016. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Geneos Wealth Management held 17 shares of ResMed worth $3.31K as of Q2 2026.
Geneos Wealth Management bought 13 ResMed shares in Q2 2026, an estimated $2.69K.
ResMed made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #2257 holding.
Geneos Wealth Management first reported a position in ResMed in Q1 2016 and has held it in 30 quarters since.
Geneos Wealth Management's ResMed position peaked at $93K in Q1 2016.
880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.